Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/05 → 6/30/07 |
A Randomized Multi-Center Open Label Study of BMS-354825 vs. Imatinib Mesylate (Gleevec) 800 mg/d in Subjects with Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia Who Have Disease That is Resistant to Imatinib
- Brown, Randy (PI)